ABBV - Public Citizen petitions FDA for stricter warnings against Botox similar drugs
2023-12-12 10:33:17 ET
More on AbbVie, Evolus, etc.
- AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition
- AbbVie: Risky Purchase Of ImmunoGen Could Pay Off Big Time
- AbbVie: $10 Billion Cancer Deal To Boost Growth
- AbbVie upgraded at Goldman Sachs on improving outlook
- AbbVie-Genmab lymphoma drug shows strong response rate in ongoing trial
For further details see:
Public Citizen petitions FDA for stricter warnings against Botox, similar drugs